Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China flag China · Delayed Price · Currency is CNY
9.19
+0.19 (2.11%)
At close: Aug 3, 2026

SHE:301126 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Revenue
5,2295,1445,2333,9043,2922,592
Revenue Growth
-0.46%-1.70%34.07%18.56%27.01%10.79%
Gross Profit
945.83932.121,036568.05391.68300.35
Operating Income
81.0783.14196.75122.61108.23128.3
Net Income
-239.64-242.4626.5734.351.0868.26
Earnings Per Share
-1.11-1.180.130.170.250.44
EPS Growth
---23.53%-32.00%-43.18%4.76%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Dec '21
Pharmaceutical Distribution
1,9602,2142,3012,2761,880
Pharmaceutical Retail
2,9422,6921,505993.4691.07
Hospital income
10.6614.4112.779.4514.77
Drug production revenue
215.15299.8475.85--
Other Income
16.8613.338.43--
Total
5,1445,2333,9043,2922,592

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Investments
529.87596.55619.85649.4643748.07
Total Debt
3,6653,6723,2862,5741,610753.41
Net Cash (Debt)
-3,135-3,075-2,666-1,925-967.4-5.34
Net Cash Growth
------
Net Cash Per Share
-14.52-14.97-13.04-9.54-4.73-0.03

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Cash Flow
-15.71-149.1224.0427.13-493.96-161.81
Capital Expenditures
-93.46-104.63-187.14-226.7-208.73-33.29
Free Cash Flow
-109.17-253.75-163.1-199.57-702.69-195.1
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Gross Margin
18.09%18.12%19.80%14.55%11.90%11.59%
Operating Margin
1.55%1.62%3.76%3.14%3.29%4.95%
Pretax Margin
-4.20%-4.28%1.45%1.24%2.31%3.70%
Profit Margin
-4.58%-4.71%0.51%0.88%1.55%2.63%
FCF Margin
-2.09%-4.93%-3.12%-5.11%-21.34%-7.53%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Dividend Per Share
0.1040.0220.0820.0400.0290.034
Dividend Per Share Growth
0%-73.11%104.50%37.93%-14.71%-
Dividend Yield
1.13%0.18%0.79%0.31%0.20%0.15%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
PE Ratio
--80.6978.4560.2068.65
PS Ratio
0.360.490.410.690.931.81